Original language | English |
---|---|
Pages (from-to) | 1964-2012 |
Journal | Lancet (London, England) |
Volume | 401 |
Issue number | 10392 |
Early online date | 18 May 2023 |
DOIs | |
Publication status | Published - 10 Jun 2023 |
Keywords / Materials (for Non-textual outputs)
- Health Promotion
- Health Services Accessibility
- Humans
- Universal Health Insurance
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Lancet (London, England), Vol. 401, No. 10392, 10.06.2023, p. 1964-2012.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Lancet Commission on synergies between universal health coverage, health security, and health promotion
AU - Agyepong, Irene
AU - Spicer, Neil
AU - Ooms, Gorik
AU - Jahn, Albrecht
AU - Bärnighausen, Till
AU - Beiersmann, Claudia
AU - Brown Amoakoh, Hannah
AU - Fink, Günter
AU - Guo, Yan
AU - Hennig, Lisa
AU - Kifle Habtemariam, Mahlet
AU - Kouyaté, Bocar A
AU - Loewenson, Rene
AU - Micah, Angela
AU - Moon, Suerie
AU - Moshabela, Mosa
AU - Myhre, Sonja Lynn
AU - Ottersen, Trygve
AU - Patcharanarumol, Walaiporn
AU - Sarker, Malabika
AU - Sen, Gita
AU - Siozaki, Yasuhisa
AU - Songane, Francisco
AU - Sridhar, Devi
AU - Ssengooba, Freddie
AU - Vega, Jeanette
AU - Ventura, Deisy
AU - Voss, Maike
AU - Heymann, David
N1 - Funding Information: We thank Eirik F Vikum; the advisors the Commission: Ilona Kickbusch (Global Health Centre at Geneva Graduate Institute), Mickey Chopra (World Bank), Gloria Quansah Asare (former Deputy Director General Ghana Health Service), Agnes Soucat (French Development Agency), Kevin McCarthy (European Commission, retired), Stefaan Van Der Borght (Anglo American), Ruediger Krech (WHO), and Daniel Eiback (German Federal Ministry for Economic Cooperation and Development); and Robert Marten (Alliance for Health Policy and Systems Research). The following associations contributed to the work of the Commission via funding: the German Ministry for Economic Corperation and Development, Norweigian Agency for Development Cooperation, and Deutsche Gesellschaft für Internationale Zusammenarbeit provided general funding; the Wellcome Trust through University of Heidelberg funded ten of the 11 country case studies; the Swiss Development Cooperation through the London School of Hygiene & Tropical Medicine funded the global case study; International Development Research Centre Canada through the Dodowa Health Research Center and Doris Duke Charitable foundation funded the sub-Saharan Africa consultations; Open Society Foundation via Open Society Initiative for West Africa funded the Sierra Leone country case study; and WHO Africa Regional Office funded the attendance of HBA at the Africa health forum in Cape Verde in 2019. All analyses, opinions and conclusions expressed in this document are the independent analyses, opinions, and conclusions of the commissioners and not the funders. Funding Information: Transparency and accountability were important in Thailand during both normal and crucial situations such as the COVID-19 pandemic. For universal health coverage, values such as the right to health and equity are fundamental. For health security, values such as solidarity, active citizens, and high voluntarism are also very relevant. Thailand's holistic approach was also reflected in financing. Universal health coverage was financed through general taxes and not from external funding. Indicators suggest there was decreasing personal health expenditure and increasing domestic funding for health. Health security received designated funding from the universal health coverage scheme. Health promotion also received designated funding via the universal health coverage scheme, including a 2% surcharge on tobacco and alcohol that was directly transferred to the Thai Health Promotion Office's budget.
PY - 2023/6/10
Y1 - 2023/6/10
KW - Health Promotion
KW - Health Services Accessibility
KW - Humans
KW - Universal Health Insurance
U2 - 10.1016/S0140-6736(22)01930-4
DO - 10.1016/S0140-6736(22)01930-4
M3 - Review article
C2 - 37224836
SN - 0140-6736
VL - 401
SP - 1964
EP - 2012
JO - Lancet (London, England)
JF - Lancet (London, England)
IS - 10392
ER -